Owen Hughes Cullinan Oncology, Inc. (CGEM) insider trading activity

CGEM Quotes by TradingView

Owen Hughes is President and CEO of Cullinan Oncology, Inc.. Currently has a direct ownership of 506,226 shares of CGEM, which is worth approximately $6.37 Million. The most recent transaction as insider was on Jan 12, 2021, when has been sold 2,500 shares (Common Stock) at a price of $21.0 per share, resulting in proceeds of $52,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 506K
0% 3M change
0% 12M change
Total Value Held $6.37 Million

Owen Hughes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 12 2021
BUY
Open market or private purchase
$52,500 $21.0 p/Share
2,500 Added 0.49%
506,226 Common Stock

Also insider at

RDUS
Radius Health, Inc. Healthcare
Director
TBIO
Translate Bio, Inc. Healthcare
Director
PRDS
PARDES BIOSCIENCES, INC. Healthcare
Director
IKNA
Ikena Oncology, Inc. Healthcare
XOMA
XOMA Corp Healthcare
Chief Executive Officer
CCCC
C4 Therapeutics, Inc. Healthcare
Director
OH

Owen Hughes

President and CEO
Boston, MA

Track Institutional and Insider Activities on CGEM

Follow Cullinan Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

News

Receive news related to Cullinan Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CGEM